ZENOCUTUZUMAB
UNII AE72RB1W1X

Substance Identification & Data

This profile provides standardized clinical and technical data for Zenocutuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AE72RB1W1X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1969309-56-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

AE72RB1W1X

CAS Registry Number

1969309-56-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZENOCUTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

AE72RB1W1X

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C152948

National Cancer Institute reference terminology for clinical and research data.

INN ID

10687

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-231

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zenocutuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZENOCUTUZUMAB

ZENOCUTUZUMAB-ZBCO

Common Names & Synonyms

IMMUNOGLOBULIN G1, BISPECIFIC, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTORS, HER2 AND HER3) (HUMANIZED CLONE MCLA-128 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED CLONE MCLA-128 LIGHT CHAIN, DIMER

MCLA-128 (IGG1 BISPECIFIC ANTIBODY WITH ENHANCED ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC) ACTIVITY TARGETING HER2 AND HER3 RECEPTORS.)

ZENOCUTUZUMAB [INN]

ZENOCUTUZUMAB [USAN]

ZENOCUTUZUMAB [WHO-DD]

ZENOCUTUZUMAB ZBCO [WHO-DD]